Gout/Crystal

Autoinflammatory/Still's Disease Panel - EULAR2020

Drs. Olga Petryna, Petros Efthimiou, Apostolos Kontzias and Jack Cush discuss autoinflammatory highlights from the Virtual EULAR 2020 meeting June 3-6

Gout Review from EULAR2020

Dr. Olga Petryna reviews highlights from the virtual EULAR 2020 meeting June 3-6, 2020

Dr. John Cush RheumNow

3 months 1 week ago

When starting IV Pegloticase in #Gout, Do you start a DMARD too? #EULAR2020

k dao KDAO2011

3 months 1 week ago

#EULAR2020 ABST#OP0015Plenary session: very low serum urate < 4 mg/dL in men assc w/increased CV mortality; 40,000 pt study. NOTE: this may be driven by poorly controlled diabetes as hyperglycemia has a uricosuric effect; from NHANES database @MassGeneralNews @RheumNow https://t.co/jnhkS436JZ

Dr. John Cush RheumNow

3 months 1 week ago

When starting IV Pegloticase in #Gout, Do you start a DMARD too? #EULAR2020

Therapeutic Update

A Closer Look at Psoriatic Arthritis Outcome Measures and Disease Control
Save

Sponsored By AbbVie Medical Affairs

Sep 01, 2020

A closer Look at PsA Measures and Outcomes

Addressing the heterogeneous manifestations of psoriatic arthritis (PsA) can be challenging for physicians. But how is disease control defined in PsA? What are appropriate treatment targets for use in clinical practice? Join Dr. Alexis Ogdie and Dr. Philip Mease for an overview of composite measures used to assess disease activity and ongoing discussions surrounding disease control and treatment targets for patients with PsA.

Read Post